Clinical Trial: A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07408232) titled 'A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)' on Feb. 06.

Brief Summary: This integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy volunteers and participants with RHO-adRP.

Study Start Date: Feb. 09

Study Type: INTERVENTIONAL

Condition: Retinitis Pigmentosa

Intervention: DRUG: Phase 1a: OCT-980 Capsule

OCT-980 capsules administered orally once at dose levels specified in the protocol

DRUG: Phase 1a: Placebo Capsule

Placebo capsules administered orally once ...